On August 25, the Centers for Medicare and Medicaid Services (CMS) released performance results for the eighth performance year (2020) of the Medicare Shared Savings Program (MSSP). The results for ...
Medicare's largest alternative payment model produced its highest annual savings to date in 2020, as shown by performance data released this week by the Centers for Medicare and Medicaid Services. The ...
In 2020, Medicare spent the most on Eliquis, with more than 2.6 million Medicare Part D enrollees taking the blood thinner at a cost of nearly $10 billion, according to data released March 8 by AARP.
At the start of the COVID-19 pandemic, Medicare spending on lab tests increased overall, despite spending for non-COVID-19 tests falling for the first time since 2016, according to the Office of the ...
In early 2020, all roads in American politics led to Medicare for All. The policy demand, shorthand for a universal, ...
During the first six months of 2020, physicians reported $9.4 billion less in Medicare claims than expected at the start of the year, with spending down 19% as seniors deferred care during the ...
According to CMS data, there was a 63-fold increase in telehealth utilization in 2020 by Medicare enrollees. (Photo: fizkes/Shutterstock.com) A new report from the U.S. Department of Health and Human ...
While "Medicare for all" quickly became one of the top policy issues of the 2020 race for the Democratic presidential nomination, polling doesn't show a clear preference for a government-run health ...
HARTFORD, Conn., Oct. 24, 2019 /PRNewswire/ -- Aetna, a CVS Health company (NYSE: CVS), announced its 2020 Medicare offerings, featuring expanded plan options with low or $0 monthly premiums in most ...
There's Medicare Part A, Part B, Part D, Medigap plans, Medicare Advantage plans and so on. We sort out the confusion about ...
This equates to $1,213 per user in 2021 — down 1.4% from 2020 but the first annual decrease since 2016. Over the past 10 years, ambulance spending for Medicare beneficiaries has fallen. However, ...